Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

oxazepam (Rx)Brand and Other Names:Serax

 
 
 

Dosing & Uses

AdultPediatricGeriatric

Dosage Forms & Strengths

capsule: Schedule IV

  • 10mg
  • 15mg
  • 30mg
more...

Anxiety

Mild/moderate: 10-15 mg PO q6-8hr PRN

Severe, agitation or assoc with depression: 15-30 mg PO q6-8hr PRN

Alcohol Withdrawal

15-30 mg PO q6-8hr PRN

Dosage Forms & Strengths

capsule: Schedule IV

  • 10mg
  • 15mg
  • 30mg
more...

Anxiety

<6 years: Not recommended

6-12 years: Not established; use with caution

>12 years

  • Mild/moderate: 10-15 mg PO q6-8hr PRN
  • Severe, agitation or assoc with depression: 15-30 mg PO q6-8hr PRN

Drug of choice in elderly when benzodiazepine indicated because of short half-life

Anxiety

10 mg q8-12hr; may gradually increase to total dose of 30-45 mg/day PRN

Ethanol Withdrawal

10-30 mg PO q8-12hr PRN

Next

Interactions

Interaction Checker

oxazepam and

No Results

     
     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            Sort by :  
             activity indicator 
            Previous
            Next

            Adverse Effects

            Frequency Not Defined

            Sedation

            Ataxia

            Confusion

            Memory impairment

            Dizziness

            Drowsiness

            Muscle weakness

            Syncope edema

            Leukopenia, blood dyscrasias

            Decreased libido

            Rash

            Incontinence

            Menstrual irregularities

            Jaundice

            Blured vision; diplopia

            Previous
            Next

            Warnings

            Contraindications

            Documented hypersensitivity

            Acute alcohol intoxication

            Myasthenia gravis (allowable in limited circumstances)

            Narrow angle glaucoma (questionable)

            Severe respiratory depression

            Depressed neuroses, psychotic reactions

            IV use in shock, coma, depressed respiration, patients who recently received other respiratory depressants

            Cautions

            Use caution in respiratory diseases (COPD), cardiovascular disease (hypotension), sleep apnea, renal/hepatic disease, open-angle glaucoma (questionable), depression, suicide ideation, history of drug abuse

            May impair ability to perform hazardous tasks

            Associated with anterograde amnesia

            Paradoxical reactions (heractivity or aggressive behavior) may occur

            Use caution in debilitated patients and the elderly

            Use caution in patients with history of drug abuse or acute alcoholism; tolerance, psychological and physical dependence may occur with prolonged use

            Previous
            Next

            Pregnancy & Lactation

            Pregnancy Category: D

            Lactation: Avoid during breastfeeding

            Minor tranquilizers should be avoided in 1st trimester of pregnancy due to increased risk of congenital malformations

            Maternal use shortly before delivery is associated with floppy infant syndrome (good and consistent evidence)

            Prenatal benzodiazepine exposure slightly increased oral cleft risk (limited or inconsistent evidence)

            Pregnancy Categories

            A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

            B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

            C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

            D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

            X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

            NA:Information not available.

            more...
            Previous
            Next

            Pharmacology

            Mechanism of Action

            Binds receptors at several sites within the CNS, including the limbic system and reticular formation. Effects may be mediated through GABA receptor system. Increase in neuronal membrane permeability to chloride ions enhances the inhibitory effects of GABA; the shift in chloride ions causes hyperpolarization (less excitability) and stabilization of the nuronal membrane

            Pharmacokinetics

            Half-life elimination: 2.8-5.7 hr

            Peak plasma time: 3 hr

            Peak plasma concentration: 450 ng/mL

            Metabolism: Glucuronic acid conjugation

            Metabolites: No active metabolites

            Protein binding: 86-99%

            Excretion: Urine

            Previous
            Next

            Images

            Previous
            Next

            Formulary

            FormularyPatient Discounts

            To view formulary information first create a list of plans. Your list will be saved and can be edited at any time.

            Adding plans allows you to:

            • View the formulary and any restrictions for each plan.
            • Manage and view all your plans together – even plans in different states.
            • Compare formulary status to other drugs in the same class.
            • Access your plan list on any device – mobile or desktop.

            The above information is provided for general informational and educational purposes only. Individual plans may vary and formulary information changes. Contact the applicable plan provider for the most current information.

            Tier Description
            1 This drug is available at the lowest co-pay. Most commonly, these are generic drugs.
            2 This drug is available at a middle level co-pay. Most commonly, these are "preferred" (on formulary) brand drugs.
            3 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs.
            4 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            5 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            6 This drug is available at a higher level co-pay. Most commonly, these are "non-preferred" brand drugs or specialty prescription products.
            NC NOT COVERED – Drugs that are not covered by the plan.
            Code Definition
            PA Prior Authorization
            Drugs that require prior authorization. This restriction requires that specific clinical criteria be met prior to the approval of the prescription.
            QL Quantity Limits
            Drugs that have quantity limits associated with each prescription. This restriction typically limits the quantity of the drug that will be covered.
            ST Step Therapy
            Drugs that have step therapy associated with each prescription. This restriction typically requires that certain criteria be met prior to approval for the prescription.
            OR Other Restrictions
            Drugs that have restrictions other than prior authorization, quantity limits, and step therapy associated with each prescription.
            Add or Remove Plans
            Plans for
            Select State:
            Non-Medicare PlansMedicare Plans

            Select a box to add or remove a plan.

            Select a class to view formulary status for similar drugs

            Additional Offers
            Email to Patient

            From:

            To:

            The recipient will receive more details and instructions to access this offer.

            By clicking send, you acknowledge that you have permission to email the recipient with this information.

            Email Forms to Patient

            From:

            To:

            The recipient will receive more details and instructions to access this offer.

            By clicking send, you acknowledge that you have permission to email the recipient with this information.

            Previous
             
             
             
            All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.